TTY Biopharm Co Ltd Working Capital to Net Assets Ratio
TTY Biopharm Co Ltd working capital to net assets ratio. TTY Biopharm Co Ltd (4105) has a Working Capital to Net Assets ratio of 34.7% as of March 2026. Working capital of NT$2.57 Billion (current assets of NT$6.19 Billion minus current liabilities of NT$3.62 Billion) is measured against net assets of NT$7.40 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 4105 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of TTY Biopharm Co Ltd (2017–2025)
Working capital to net assets ratio of TTY Biopharm Co Ltd from 2017 to 2025. This chart shows how TTY Biopharm Co Ltd's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at 34.7%, reflecting working capital of NT$2.57 Billion against net assets of NT$7.40 Billion TWD. See TTY Biopharm Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
TTY Biopharm Co Ltd Working Capital to Net Assets Ratio by Year (2017–2025)
TTY Biopharm Co Ltd working capital to net assets ratio by year from 2017 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for TTY Biopharm Co Ltd from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 4105 asset base.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 41.8% | NT$3.37 Billion | NT$8.05 Billion | NT$6.01 Billion | NT$2.64 Billion | ▲ +2.8 pp |
| 2024 | 39.0% | NT$2.93 Billion | NT$7.51 Billion | NT$5.79 Billion | NT$2.86 Billion | ▼ -3.8 pp |
| 2023 | 42.8% | NT$2.79 Billion | NT$6.51 Billion | NT$5.37 Billion | NT$2.58 Billion | ▲ +8.9 pp |
| 2022 | 34.0% | NT$2.12 Billion | NT$6.23 Billion | NT$5.04 Billion | NT$2.92 Billion | ▲ +4.5 pp |
| 2021 | 29.4% | NT$1.70 Billion | NT$5.77 Billion | NT$4.75 Billion | NT$3.05 Billion | ▼ -7.6 pp |
| 2020 | 37.0% | NT$2.25 Billion | NT$6.08 Billion | NT$4.80 Billion | NT$2.55 Billion | ▲ +5.4 pp |
| 2019 | 31.6% | NT$1.95 Billion | NT$6.17 Billion | NT$4.97 Billion | NT$3.03 Billion | ▼ -10.4 pp |
| 2018 | 42.0% | NT$2.68 Billion | NT$6.39 Billion | NT$4.65 Billion | NT$1.97 Billion | ▲ +5.8 pp |
| 2017 | 36.2% | NT$2.21 Billion | NT$6.11 Billion | NT$5.00 Billion | NT$2.78 Billion | — |